Jasper Therapeutics, Inc. (JSPR) Net income 2020–2025
Jasper Therapeutics, Inc. (JSPR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$75.8MFY2025 · since FY2020: -$31.7M → -$75.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$75.8M | -6.4% |
| FY2024 | -$71.3M | -10.6% |
| FY2023 | -$64.5M | -71.1% |
| FY2022 | -$37.7M | -23.0% |
| FY2021 | -$30.6M | +3.3% |
| FY2020 | -$31.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More JSPR financial trends
JSPR RevenueJSPR Net marginJSPR Gross profitJSPR Gross marginJSPR Operating incomeJSPR Operating marginJSPR Operating cash flowJSPR Free cash flowJSPR Capital expendituresJSPR Return on equityJSPR Stock buybacksJSPR Dividends paidJSPR Total assetsJSPR Total liabilitiesJSPR Shareholders’ equityJSPR overview →